ArticlePsychiatric services (Washington, D.C.)2017
Perceived Autonomy Support in the NIMH RAISE Early Treatment Program.
Abstract read
In one paragraph
Article in Psychiatric services (Washington, D.C.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention Strategies.Schizophrenia bulletin · 2024Pooled it
- A Systematic Review of Shared Decision-Making Interventions for Service Users With Serious Mental Illnesses: State of the Science and Future Directions.Psychiatric services (Washington, D.C.) · 2021Pooled it
- Autonomy Support from Healthcare Professionals Improves Functioning in Early Psychosis Through Psychological Growth.Schizophrenia bulletin · 2026Trial
- Relationship between patterns of cannabis use and functional and symptomatic trajectories in first-episode psychosis.European archives of psychiatry and clinical neuroscience · 2023Trial
- Personal Agency Support Questionnaire in Acute Psychiatric Inpatients: Development and Instrument Validation Study.Asian/Pacific Island nursing journal · 2026Article
- A Mixed Methods Study of Program-Level Factors Influencing Patient and Family Engagement in First Episode Psychosis Coordinated Specialty Care.medRxiv : the preprint server for health sciences · 2026Article
- Review
- Disengagement from early psychosis intervention services: an observational study informed by a survey of patient and family perspectives.Schizophrenia (Heidelberg, Germany) · 2022Article
- Treatment decision-making needs among emerging adults with early psychosis.Early intervention in psychiatry · 2022Article
- Evaluating the feasibility of a decision aid to promote shared decision making among young adults with first-episode psychosis: protocol for a pilot study.Pilot and feasibility studies · 2021Article
- Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative.Annual review of clinical psychology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Julia BrowneMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
David L PennMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
Daniel J BauerMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
Piper Meyer-KalosMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
Kim T MueserMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
Delbert G RobinsonMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
Jean AddingtonMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
Nina R SchoolerMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
Shirley M GlynnMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
Susan GingerichMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
Patricia MarcyMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
John M KaneMs. Browne, Dr. Penn, and Dr. Bauer are with the Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill. Dr. Penn is also with the School of Psychology, Australian Catholic University, Melbourne. Dr. Meyer-Kalos is with the School of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Robinson, Dr. Schooler, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York. Dr. Robinson is also with Departments of Psychiatry and Molecular Medicine, Hofstra University-North Shore Long Island Jewish School of Medicine, Hempstead, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Addington is with the Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Dr. Glynn is with the Semel Institute for Neuroscience and Brain Behavior, University of California, Los Angeles, Los Angeles. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania.
Funding
COURSE OF ILLNESS IN SCHIZOPHRENIA: OPTIMIZING OUTCOMESP30MH060575 · NIMH · LONG ISLAND JEWISH MEDICAL CENTER · PI KANE, JOHN M · 2000 to 2004
$6.5MLongitudinal Mediation Analysis to Identify Effective Intervention Components in Clustered Trial of RAISE-ETP (Recovery after an Initial Schizophrenia Episode-Early Treatment Program)R03MH112053 · NIMH · YALE UNIVERSITY · PI LIN, HAIQUN · 2017 to 2018
$168kNIMH NIH HHS P30 MH060575NIMH NIH HHS R03 MH112053
Abstract
objectiveThis study examined perceived support for autonomy-the extent to which individuals feel empowered and supported to make informed choices-among participants in the Recovery After an Initial Schizophrenia Episode Early Treatment Program (RAISE ETP). The aims of this study were to evaluate whether NAVIGATE, the active treatment studied in RAISE ETP, was associated with greater improvements in perceived autonomy support over the two-year intervention, compared with community care, and to examine associations between perceived autonomy support and quality of life and symptoms over time and across treatment groups.
methodsThis study examined perceived autonomy support among the 404 individuals with first-episode psychosis who participated in the RAISE ETP trial (NAVIGATE, N=223; community care, N=181). Three-level conditional linear growth modeling was used given the nested data structure.
resultsThe results indicated that perceived autonomy support increased significantly over time for those in NAVIGATE but not in community care. Once treatment began, higher perceived autonomy support was related to higher quality of life at six, 12, and 18 months in NAVIGATE and at 12, 18, and 24 months in community care. Higher perceived autonomy support was related to improved scores on total symptoms and on excited symptoms regardless of treatment group and time.
conclusionsOverall, perceived autonomy support increased in NAVIGATE but not for those in community care and was related to improved quality of life and symptoms across both treatment groups. Future research should examine the impact of perceived autonomy support on a wider array of outcomes, including engagement, medication adherence, and functioning.
Indexed as
National Institute of Mental Health (U.S.)Outcome and Process Assessment, Health CarePersonal AutonomySocial SupportAdultCommunity Health ServicesEarly Medical InterventionFemaleHumansMalePsychotic DisordersSchizophreniaUnited StatesYoung AdultPsychosesPsychotherapyRecoverySchizophrenia
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.